SCHEMBL26512355

SCHEMBL26512355

COc1ccc(N/N=C2\C(=N)NN=C2N)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 10/20 0.39
MAPT P10636 9/20 0.39
ALDH1A1 P00352 5/20 0.39
NR4A1 P22736 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
RAB9A P51151 5/20 0.36
TDP1 Q9NUW8 4/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
THRB P10828 2/20 0.36
MAPK1 P28482 2/20 0.36
RECQL P46063 2/20 0.36
NPC1 O15118 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTT P42858 2/20 0.34
MMP14 P50281 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
GFER P55789 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL924770 0.77 NR4A1 (0.46) GAAMAPTALDH1A1NR4A1KMT2A
SCHEMBL921588 0.72 GAA (0.41) GAAMAPTALDH1A1NR4A1KMT2A
SCHEMBL921590 0.72 GAA (0.41) GAAMAPTALDH1A1NR4A1KMT2A
SCHEMBL6971597 0.71 GAA (0.53) GAAMAPTALDH1A1KMT2AMEN1
SCHEMBL15078965 0.64 MAPT (0.56) GAAMAPTALDH1A1NR4A1KMT2A
SCHEMBL6971595 0.62 MAPT (0.53) GAAMAPTALDH1A1NR4A1KMT2A
SCHEMBL2776448 0.62 MAPT (0.58) GAAMAPTALDH1A1NR4A1KMT2A
SCHEMBL924345 0.61 MEN1 (0.46) GAAMAPTALDH1A1KMT2AMEN1
SCHEMBL15047088 0.60 MAPT (0.56) GAAMAPTALDH1A1NR4A1KMT2A
SCHEMBL13576584 0.60 PIM1 (0.46) GAAMAPTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES UNIV COPENHAGEN (DK) 2023-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230321043-A1 COMPOUNDS HAVING PSEUDOMONAS ANTI-BIOFILM PROPERTIES GMPS, PDE11A, CGAS GAA 637/4885MAPT 375/4885ALDH1A1 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.